Exclusive Lead Generation for Bariatric Surgery Practices

Managing Patient Expectations Amid Rising Obesity Prevalence

With adult obesity rates at or above in 23 states as of 2023, bariatric surgery practices face increasing pressure to set realistic expectations around excess weight loss (EWL) and non-scale victories (NSV). Patients often conflate surgical intervention with guaranteed outcomes, overlooking risks like dumping syndrome, GERD exacerbation, or the need for pouch/stoma revision. Clear communication about restrictive vs. malabsorptive procedures, long-term malabsorption monitoring, and band erosion/slippage risks is essential — yet time-consuming for surgical teams already managing preoperative workups and MBS AQIP compliance.

Surgical Complication Liability and Malpractice Exposure

Allegations related to surgical treatment account for of bariatric surgery malpractice claims, with over half involving permanent injury or death. Complications such as anastomotic leakage, perforation, bowel obstruction, and stoma stenosis drive both clinical severity and financial risk. Practices must balance high-volume patient acquisition with rigorous preoperative screening, intraoperative precision, and postoperative surveillance — all while maintaining MBS AQIP accreditation standards that demand transparent outcome reporting and complication tracking.

Insurance Authorization Delays and GLP-1 Cost Competition

Prior authorization denials and payer-mandated conservative management trials delay surgical scheduling by weeks or months. Meanwhile, GLP-1 agonist therapy costs approximately $17,000 more than sleeve gastrectomy over two years ($58,600 vs. $41,400), yet insurers increasingly steer patients toward pharmacotherapy first. Practices absorb administrative burden appealing denials, documenting medical necessity, and navigating payer-specific criteria — all while patients with BMI ≥40 or ≥35 with comorbidities wait for coverage decisions that impact surgical timing and outcomes.

Increased Conversion Rates

Exclusive, consent-recorded leads delivered with AI voice, SMS, and email follow-up within five minutes — 24/7 — ensure bariatric surgery practices connect with motivated patients during the critical decision window. Leads arrive in your CRM (Salesforce, HubSpot, or provisioned same-day) with full consent trails: disclosure text, timestamp, IP address, and named contacting party. No shared inboxes, no capped-shared ambiguity — exclusive means exclusive.

Contacting a lead within five minutes makes contact roughly 100x more likely than at thirty minutes

Improved Patient Outcomes

Dead lead reactivation revives your existing opted-in database — patients who attended seminars, completed intake forms, or stalled at insurance verification. Multi-channel AI sequence (SMS first, voice follow-up, email backup) re-engages and qualifies contacts, pushing warm leads back into your CRM. DNC-scrubbed, FCC one-to-one consent compliant, typically 8–of dormant databases re-engage. Reactivation priced at 60–below new-lead cost.

Typically 8–of a dormant database re-engages

Reduced No-Show Rates

AI Speed-to-Lead follow-up qualifies intent and books consultations or hands off warm contacts before patients schedule with competing MBS AQIP-accredited centers. Every lead — fresh or reactivated — receives AI voice, SMS, and email within minutes, reducing no-shows for preoperative evaluations and postoperative follow-ups. Leads land via webhook, Zapier, or native integration into your EHR/CRM with consent records attached for compliance audits.

of buyers choose whoever responds first

Get Started

Tell us about your bariatric surgery practice and goals.

Exclusive Lead Generation

We source fresh, exclusive leads for your practice.

AI-Driven Follow-Up

Our AI technology follows up with leads in minutes, increasing conversion rates.